Equities

Respiri Ltd

Respiri Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.028
  • Today's Change-0.002 / -6.67%
  • Shares traded464.05k
  • 1 Year change-54.10%
  • Beta-0.0555
Data delayed at least 20 minutes, as of Mar 28 2024 04:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Respiri Limited is an Australia-based e-health software as a service company that supports respiratory health management. It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. Wheezo is used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children for more than two years. It also offers connected care solutions for management of people living with chronic diseases.

  • Revenue in AUD (TTM)794.32k
  • Net income in AUD-6.39m
  • Incorporated1987
  • Employees2.00
  • Location
    Respiri LtdSuite 1, Level 9, 432 St Kilda Road,MELBOURNE 3004AustraliaAUS
  • Phone+61 39653-9160
  • Fax+61 39822-7735
  • Websitehttps://respiri.co/us/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Highcom Ltd55.97m-13.45m15.40m----0.5336--0.2752-0.1316-0.13160.55050.28111.291.9417.40---30.933.75-37.017.3322.2633.50-24.033.220.8596--0.0844--52.5838.886.18112.9341.20--
Atomo Diagnostics Ltd3.11m-7.37m19.82m----1.45--6.38-0.0124-0.01240.00520.02140.17610.96342.18---41.73-31.79-44.36-35.8841.9742.26-237.01-130.747.06--0.0124---79.3854.68-74.49---8.99--
Cardiex Ltd12.90m-9.41m22.36m26.00--502.99--1.73-0.0611-0.06110.07480.00020.83110.465524.75---60.59-72.35-238.37-127.5392.9081.46-72.90-182.600.847-3.380.9972--8.053.86-59.93--74.79--
Cleanspace Holdings Ltd13.66m-5.44m27.06m----1.35--1.98-0.0706-0.07060.17710.25840.45231.104.85---18.02-2.29-21.72-2.9070.4074.09-39.83-2.763.72--0.1562---9.479.3827.92---50.70--
Respiri Ltd794.32k-6.39m29.68m2.00--8.43--37.36-0.0074-0.00740.00090.00330.16760.01182.79---134.72-179.16-219.11-301.2297.01---803.86-640.451.09-78.800.032---15.01-5.5112.82--22.51--
Resonance Health Ltd5.74m-1.09m31.28m18.00--3.32--5.45-0.0025-0.00250.0130.02110.5077--4.93---9.61-1.60-10.51-1.71-----18.93-4.00----0.0316--17.759.1531.65---3.06--
Osteopore Ltd2.22m-4.87m34.08m----40.06--15.37-0.0842-0.08420.03830.00750.5812.083.23---127.65---387.70--73.78---219.71--0.7468-449.000.734--31.02---16.13------
Somnomed Ltd88.78m-10.51m41.81m300.00--1.40--0.4709-0.1185-0.11971.010.27541.387.767.52---16.35-5.23-22.50-7.8461.7660.17-11.84-4.131.45-2.030.3827--15.215.56-77.73--24.17--
Data as of Mar 28 2024. Currency figures normalised to Respiri Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.